目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Imaging devices - Market size and forecast 2020-2025
Microscopes - Market size and forecast 2020-2025
Immunoassays - Market size and forecast 2020-2025
Molecular diagnostics - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Agfa-Gevaert NV
Bayer AG
Bio-Therapeutic Inc.
Caliber Imaging & Diagnostics Inc.
Canfield Scientific Inc.
F. Hoffmann-La Roche Ltd.
HEINE Optotechnik GmbH and Co. KG
HILL ROM HOLDINGS INC.
Michelson Diagnostics Inc.
Strata Skin Sciences Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Imaging devices - Market size and forecast 2020-2025 ($ million)
24: Imaging devices - Year-over-year growth 2020-2025 (%)
25: Microscopes - Market size and forecast 2020-2025 ($ million)
26: Microscopes - Year-over-year growth 2020-2025 (%)
27: Immunoassays - Market size and forecast 2020-2025 ($ million)
28: Immunoassays - Year-over-year growth 2020-2025 (%)
29: Molecular diagnostics - Market size and forecast 2020-2025 ($ million)
30: Molecular diagnostics - Year-over-year growth 2020-2025 (%)
31: Others - Market size and forecast 2020-2025 ($ million)
32: Others - Year-over-year growth 2020-2025 (%)
33: Market opportunity by Type
34: Customer landscape
35: Market share By Geographical Landscape 2020-2025 (%)
36: Geographic comparison
37: North America - Market size and forecast 2020-2025 ($ million)
38: North America - Year-over-year growth 2020-2025 (%)
39: Europe - Market size and forecast 2020-2025 ($ million)
40: Europe - Year-over-year growth 2020-2025 (%)
41: Asia - Market size and forecast 2020-2025 ($ million)
42: Asia - Year-over-year growth 2020-2025 (%)
43: ROW - Market size and forecast 2020-2025 ($ million)
44: ROW - Year-over-year growth 2020-2025 (%)
45: Key leading countries
46: Market opportunity By Geographical Landscape ($ million)
47: Impact of drivers and challenges
48: Vendor landscape
49: Landscape disruption
50: Industry risks
51: Vendors covered
52: Market positioning of vendors
53: Agfa-Gevaert NV - Overview
54: Agfa-Gevaert NV - Business segments
55: Agfa-Gevaert NV - Key offerings
56: Agfa-Gevaert NV - Key customers
57: Agfa-Gevaert NV - Segment focus
58: Bayer AG - Overview
59: Bayer AG - Business segments
60: Bayer AG - Key offerings
61: Bayer AG - Key customers
62: Bayer AG - Segment focus
63: Bio-Therapeutic Inc. - Overview
64: Bio-Therapeutic Inc. - Product and service
65: Bio-Therapeutic Inc. - Key offerings
66: Bio-Therapeutic Inc. - Key customers
67: Bio-Therapeutic Inc. - Segment focus
68: Caliber Imaging & Diagnostics Inc. - Overview
69: Caliber Imaging & Diagnostics Inc. - Product and service
70: Caliber Imaging & Diagnostics Inc. - Key offerings
71: Caliber Imaging & Diagnostics Inc. - Key customers
72: Caliber Imaging & Diagnostics Inc. - Segment focus
73: Canfield Scientific Inc. - Overview
74: Canfield Scientific Inc. - Business segments
75: Canfield Scientific Inc. - Key offerings
76: Canfield Scientific Inc. - Key customers
77: Canfield Scientific Inc. - Segment focus
78: F. Hoffmann-La Roche Ltd. - Overview
79: F. Hoffmann-La Roche Ltd. - Business segments
80: F. Hoffmann-La Roche Ltd. - Key offerings
81: F. Hoffmann-La Roche Ltd. - Key customers
82: F. Hoffmann-La Roche Ltd. - Segment focus
83: HEINE Optotechnik GmbH and Co. KG - Overview
84: HEINE Optotechnik GmbH and Co. KG - Product and service
85: HEINE Optotechnik GmbH and Co. KG - Key offerings
86: HEINE Optotechnik GmbH and Co. KG - Key customers
87: HEINE Optotechnik GmbH and Co. KG - Segment focus
88: HILL ROM HOLDINGS INC. - Overview
89: HILL ROM HOLDINGS INC. - Business segments
90: HILL ROM HOLDINGS INC. - Key offerings
91: HILL ROM HOLDINGS INC. - Key customers
92: HILL ROM HOLDINGS INC. - Segment focus
93: Michelson Diagnostics Inc. - Overview
94: Michelson Diagnostics Inc. - Product and service
95: Michelson Diagnostics Inc. - Key offerings
96: Michelson Diagnostics Inc. - Key customers
97: Michelson Diagnostics Inc. - Segment focus
98: Strata Skin Sciences Inc. - Overview
99: Strata Skin Sciences Inc. - Business segments
100: Strata Skin Sciences Inc. - Key offerings
101: Strata Skin Sciences Inc. - Key customers
102: Strata Skin Sciences Inc. - Segment focus
103: Currency conversion rates for US$
104: Research Methodology
105: Validation techniques employed for market sizing
106: Information sources
107: List of abbreviations